Synthesis and characterization of a molecularly imprinted polymer (MIP) for solid-phase extraction of the antidiabetic gliclazide from human plasma
Autor: | Christian Fernandes, Ingrid Vasconcelos, Maria Betânia de Freitas Marques, Roberto F. S. Freitas, Pedro Henrique Reis da Silva, Wagner da Nova Mussel, Derick Rodrigues Davila Dias, Ricardo Geraldo de Sousa, Tércio Assunção Pedrosa, Maria Elisa Scarpelli Ribeiro e Silva |
---|---|
Rok vydání: | 2020 |
Předmět: |
Bioanalysis
Materials science Sorbent medicine.drug_class Sample preparation Bioengineering 02 engineering and technology 010402 general chemistry 01 natural sciences Molecularly imprinted solid-phase extraction Molecular Imprinting Biomaterials Diabetes mellitus Molecularly Imprinted Polymers medicine Humans Hypoglycemic Agents Gliclazide Solid phase extraction Chromatography High Pressure Liquid Aged Chromatography Solid Phase Extraction Extraction (chemistry) Molecularly imprinted polymer Sulphonylureas 021001 nanoscience & nanotechnology Sulfonylurea 0104 chemical sciences Gliclazida Diabetes Mellitus Type 2 Pharmaceutical Preparations Mechanics of Materials 0210 nano-technology medicine.drug |
Zdroj: | Repositório Institucional da UFMG Universidade Federal de Minas Gerais (UFMG) instacron:UFMG |
ISSN: | 0928-4931 |
Popis: | CNPq - Conselho Nacional de Desenvolvimento Científico e Tecnológico FAPEMIG - Fundação de Amparo à Pesquisa do Estado de Minas Gerais CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior Outra Agência Gliclazide is a sulfonylurea frequently prescribed for the management of type 2 diabetes mellitus in elderly patients and for patients with chronic renal or hepatic diseases. Even though it is considered a safer alternative, the drug can provoke side effects in some patients, especially hypoglycemia, due to the high interindividual variability. Therefore, the quantification of gliclazide in biological samples is usually recommended in order to assure efficacy and safety of the pharmacotherapy. However, due to the complexity of biological matrices, therapeutic monitoring can be very challenging, especially in the sample preparation step. For that reason, the synthesis and characterization of a novel and selective molecularly imprinted polymer (MIP) was proposed to be employed as sorbent for the extraction of gliclazide from human plasma samples by a molecularly imprinted solid-phase extraction (MISPE) procedure. Synthesis conditions were optimized (monomer, crosslinker and porogen) and the polymer was characterized for its morphological, physicochemical and stability properties. The influence of drug concentration, solvent composition and pH on the coefficient of distribution (Kd) and imprinting factor (IF) were studied, as well as repeatability between batches and selectivity. A bioanalytical method was developed applying the developed MIP as sorbent in solid phase extraction and liquid chromatography using a Poroshell 120 C18 (100 × 4.6 mm, 4 μm) column, acetonitrile and 10 mM potassium phosphate buffer pH 3.0 (50:50) at a flow-rate of 1.2 mL/min as mobile phase, temperature of 30 °C, injection volume of 40 μL and detection at 230 nm. The best reaction yield, extraction capacity, and selectivity was obtained using 2-hydroxyethyl methacrylate (2-HEMA), ethyleneglycol dimethacrylate (EGDMA) and acetonitrile. The optimized MIP showed coefficient of distribution (Kd) of 59.85 μg/g, imprinting factor (IF) of 1.60, and selectivity for gliclazide and other sulfonylureas compared to possible concurrent drugs. The developed method by MISPE-HPLC-UV showed to be appropriate to determine gliclazide in human plasma samples. |
Databáze: | OpenAIRE |
Externí odkaz: |